FUJIFILM Diosynth Biotechnologies, a world leading contract development and manufacturing organisation (CDMO) for biologics, viral vaccines and viral vectors, has confirmed a £400 million planned investment package at its UK facility in Billingham, Teesside. This investment package more than doubles the site’s existing development and manufacturing footprint, creating the largest multi-modal biopharmaceutical manufacturing site in the United Kingdom and is expected to create up to 350 highly-skilled jobs.
- Read more about FUJIFILM Diosynth Biotechnologies to investment 400 million pound at its UK facility
- Log in or register to post comments
source https://www.pharmatutor.org/pharma-news/2021/fujifilm-diosynth-biotechnologies-to-investment-400-million-pound-at-its-uk-facility
No comments:
Post a Comment